Genentech-Earendil Labs AI bispecific antibody research collaboration
Disclosed: Verified: Partners: Earendil Labs
Earendil Labs announced a research collaboration with Genentech (Roche Group) to discover bispecific antibodies in oncology using Earendil's AI-driven biologics platform; Earendil reports $55 million upfront and potential value above $1.5 billion.